Cargando…

The impact of influenza vaccination on cardiovascular diseases

The link between influenza and medical complications is well stablished and plays a role in the high mortality rates of this disease. Available scientific evidence suggests that influenza vaccination might reduce the risk of cardiovascular events. This setting for cardiovascular prevention beyond im...

Descripción completa

Detalles Bibliográficos
Autor principal:	Carro, Amelia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Influenza and cardiovascular outcomes – benefits of vaccination in the age of COVID 19 Supplement Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930098/ https://www.ncbi.nlm.nih.gov/pubmed/36816329 http://dx.doi.org/10.1093/eurheartjsupp/suac126

Ejemplares similares

A recent experience on the role of influenza vaccination on cardiovascular events
por: Sosa-Liprandi, María Inés, et al.
Publicado: (2023)

Vaccines and cardiovascular outcomes: lessons learned from influenza epidemics
por: Yedlapati, Siva H, et al.
Publicado: (2023)

Influenza and cardiovascular disease pathophysiology: strings attached
por: Skaarup, Kristoffer Grundtvig, et al.
Publicado: (2023)

The impact of COVID-19 and COVID vaccination on cardiovascular outcomes
por: Akhtar, Zubair, et al.
Publicado: (2023)

Influenza vaccination in patients affected by diabetes
por: Verket, Marlo, et al.
Publicado: (2023)

What if flu vaccination is the most responsible thing to do for cardiovascular health in the upcoming season?
por: Volpe, Massimo, et al.
Publicado: (2023)

Myocardial infarction and viral triggers: what do we know by now?
por: Caldeira, Daniel, et al.
Publicado: (2023)

Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases
por: Finckh, Axel, et al.
Publicado: (2023)

The Burden of COVID-19 in the Immunocompromised Patient: Implications for Vaccination and Needs for the Future
por: Antinori, Andrea, et al.
Publicado: (2023)

A Call to Action: Current Challenges and Considerations for COVID-19 Vaccination in Immunocompromised Populations
por: Bonanni, Paolo, et al.
Publicado: (2023)

SARS-CoV-2 Infection and Response to COVID-19 Vaccination in Patients With Primary Immunodeficiencies
por: Paris, Robert
Publicado: (2023)

Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults
por: Sanz-Muñoz, Iván, et al.
Publicado: (2023)

Estimating the impact of influenza vaccination of low-risk 50–64-year-olds on acute and ICU hospital bed usage in an influenza season under endemic COVID-19 in the UK
por: Nguyen, Van Hung, et al.
Publicado: (2023)

Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants
por: Subramanian, Vijay
Publicado: (2023)

COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future
por: Hall, Victoria G, et al.
Publicado: (2023)

COVID-19 Vaccination Among Patients Receiving Maintenance Renal Replacement Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future
por: Rouphael, Nadine, et al.
Publicado: (2023)

Seasonal Influenza Vaccine Allocation in the Canadian Population during a Pandemic
por: Tuite, Ashleigh, et al.
Publicado: (2009)

Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season
por: Amicizia, Daniela, et al.
Publicado: (2023)

The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why?
por: Raude, Jocelyn, et al.
Publicado: (2010)

Gap between cognitions and behaviors among children’s guardians of influenza vaccination: The role of social influence and vaccine-related knowledge
por: Wu, Jing, et al.
Publicado: (2023)

PREVALENCE OF ANTIBODIES AGAINST INFLUENZA VIRUS IN NON-VACCINATED EQUINES FROM THE BRAZILIAN PANTANAL
por: Silva, Lucas Gaíva E, et al.
Publicado: (2014)

Influenza vaccine coverage in 6months-64 years-old patients affected by chronic diseases: A retrospective cohort study in Italy
por: Bianchi, Francesco Paolo, et al.
Publicado: (2023)

Quantifying Protection Against Influenza Virus Infection Measured by Hemagglutination-inhibition Assays in Vaccine Trials
por: Zhao, Xiahong, et al.
Publicado: (2016)

Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design
por: Zimmerman, Richard K., et al.
Publicado: (2023)

Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: Clinical and economic impact
por: Deuffic-Burban, Sylvie, et al.
Publicado: (2009)

Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis
por: Wei, Xia, et al.
Publicado: (2023)

Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

Reply letter to “Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design”
por: Hadigal, Sanjay, et al.
Publicado: (2023)

Foreword: Preventing COVID-19 Among the Immunocompromised Population
por: Willicombe, Michelle
Publicado: (2023)

Parental intention to vaccinate children against seasonal influenza in the Eastern Mediterranean region: A cross-sectional study using the health belief model
por: Fadl, Noha, et al.
Publicado: (2023)

Knowledge, attitudes, concern, behaviors, and barriers associated with the readiness to receive seasonal influenza vaccine among healthcare workers in oncology setting during the COVID-19 pandemic
por: Mubarak, Sawsan, et al.
Publicado: (2023)

Efficient simulation of the spatial transmission dynamics of influenza
por: Tsai, Meng-Tsung, et al.
Publicado: (2010)

Tempo and Mode in the Molecular Evolution of Influenza C
por: Gatherer, Derek
Publicado: (2010)

Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial
por: Chen, Jianmin, et al.
Publicado: (2023)

Absolute Humidity and the Seasonal Onset of Influenza in the Continental US
por: Shaman, Jeffrey, et al.
Publicado: (2010)

Prevalence of antibodies against seasonal influenza A and B viruses during the 2009-2010 and 2010-2011 influenza seasons in residents of Pittsburgh, PA, USA.
por: Ross, Ted M., et al.
Publicado: (2011)

Projection of seasonal influenza severity from sequence and serological data
por: Wolf, Yuri I, et al.
Publicado: (2010)

Urbanization and humidity shape the intensity of influenza epidemics in U.S. cities
por: Dalziel, Benjamin D., et al.
Publicado: (2018)

The early diversification of influenza A/H1N1pdm
por: Nelson, Martha, et al.
Publicado: (2009)

Quantifying the transmissibility of human influenza and its seasonal variation in temperate regions
por: Truscott, James, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2qf2jjsaap68r9kmubv0dt206r